Form 4: STERIS plc: Executive Stock Vesting and Tax Withholding

STERIS plc reports on executive stock vesting and tax withholding for President and CEO Daniel A. Carestio, detailing share transactions and beneficial ownership.

Summary

• Daniel A. Carestio, President and CEO of STERIS plc, reported a transaction on June 1, 2026, related to the vesting of restricted shares.
• A total of 1,254 ordinary shares were withheld to cover applicable taxes required by employment or tax laws.
• These withheld shares were valued at the NYSE closing market price on June 1, 2026.
• Following this transaction, Mr. Carestio beneficially owns 49,842 ordinary shares directly.
• Of the total ordinary shares held, 28,746 are currently restricted, with restrictions lapsing on various dates through June 5, 2028.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine executive stock vesting and tax withholding, which are standard operational events rather than indicators of significant company performance or strategic shifts.

Positives

• Vesting of restricted shares indicates continued performance and commitment from key executive leadership.
• The withholding of shares for tax purposes is a standard and responsible practice, ensuring compliance with tax obligations.
• Mr. Carestio's direct beneficial ownership of 49,842 shares demonstrates a significant personal stake in the company's success.

Negatives

• A portion of vested shares (1,254) were withheld, reducing the immediate net shares received by the executive.

Risks

• Restrictions on 28,746 ordinary shares will lapse over time, potentially leading to future sales that could impact share price if not managed strategically.
• The valuation of withheld shares is tied to the NYSE closing market price on June 1, 2026, which could fluctuate.

Future Outlook

The filing details the scheduled lapse of restrictions on 28,746 ordinary shares through June 5, 2028, indicating future potential changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that executive stock vesting and tax withholding are standard components of compensation packages in the healthcare technology and services industry, designed to align executive interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The vesting and potential future sale of restricted shares could influence the stock's supply and demand dynamics.
• Executives: The transaction confirms a standard component of executive compensation and aligns executive interests with company performance through share ownership.

Next Steps

• Restrictions on 2,369 ordinary shares will lapse on June 2, 2026.
• Restrictions on 5,937 ordinary shares will lapse on June 3, 2026.
• Restrictions on 4,283 ordinary shares will lapse on June 4, 2026.
• Restrictions on 5,937 ordinary shares will lapse on June 3, 2027.
• Restrictions on 4,283 ordinary shares will lapse on June 4, 2027.
• Restrictions on 5,937 ordinary shares will lapse on June 5, 2028.

Key Dates

Keywords

STERIS plc, STE, Form 4, Stock Vesting, Tax Withholding, Beneficial Ownership, Executive Compensation, Insider Transaction, Daniel A. Carestio, Restricted Shares